We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo






  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 36

U.S. and EU authorities focus attention on competition in pharmaceutical industry

  • Hogan Lovells
  • -
  • European Union, USA
  • -
  • March 25 2008

During the past several years, there has been an increase in antitrust enforcement directed at the pharmaceutical industry, both in the United States and in Europe, primarily focused on conduct by branded pharmaceutical companies that might affect the timing and effectiveness of entry by less costly generic drugs

The patentability of stem cells: WARF's success and failure on opposite sides of the Atlantic

  • Shepherd & Wedderburn LLP
  • -
  • European Union, United Kingdom, USA
  • -
  • March 31 2008

The Wisconsin Alumni Research Foundation (WARF) has had three of its patents in relation to stem cells (and in particular, methods of isolation) upheld by the United States Patent and Trademark Office (USPTO

Product and disease registries: planning for data protection

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • April 10 2007

Biopharmaceutical companies have now seen the power of post-market approval and observational registries

Patent misuse in the pharmaceutical industry: developments in US & EU

  • Wragge & Co LLP
  • -
  • European Union, USA
  • -
  • October 31 2007

The pharmaceutical industry has been scrutinised closely by competition authorities and courts in the US and Europe

When food production leads to prosecution

  • Davis Wright Tremaine LLP
  • -
  • European Union, USA
  • -
  • March 6 2013

Over the last few weeks, two big stories have made headlines in the food industry. Beginning in early February, news media across Europe began

EU, US regulators ease process for orphan drugs

  • Gowling Lafleur Henderson LLP
  • -
  • European Union, USA
  • -
  • December 6 2007

In an effort to encourage development of drug treatments for rare diseases, the European Commission, the European Medicines Agency and the U.S. Food and Drug Administration announced steps to streamline the application process for orphan drugs

Definitions of generic competition in contracts

  • Fasken Martineau DuMoulin LLP
  • -
  • European Union, USA
  • -
  • April 6 2009

In licensing and other collaborations the onset of 'generic competition' may be cause for renegotiation of certain aspects of the agreement or reductions in payments

EMEA and FDA focus on clinical research safety and enforcement

  • McDermott Will & Emery
  • -
  • European Union, USA
  • -
  • August 20 2009

Recent policy changes emphasize the need for sponsoring organizations to be even more vigilant in establishing, updating and monitoring their systems for compliance with clinical research requirements, whether conducted domestically or in a foreign locale

Wireless industry, scientists debate results of cell phone safety study

  • Paul, Weiss, Rifkind, Wharton & Garrison LLP
  • -
  • European Union, USA
  • -
  • May 21 2010

The results of a five-year, multimillion dollar study conducted by Interphone on the health effects of cell phone use were lauded by US and European wireless industry officials who say the research validates their position against any conclusive link between mobile phone use and brain tumors

Joint public meeting to focus on bridging nanotechnology research

  • Shook Hardy & Bacon LLP
  • -
  • European Union, USA
  • -
  • February 24 2011

The National Nanotechnology Coordination Office has announced that it will spearhead a public meeting to focus on "environmental health and safety questions for nanomaterials and nanotechnology-enabled products" and to "encourage joint US-EU programs of work that would leverage resources."

Current Search

Suggested Facets

Author

Firm Name

Jurisdiction

Workarea

© Copyright 2006-2013 Globe Business Publishing Ltd | Cookies | Disclaimer | Privacy policy